SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-009379
Filing Date
2018-05-10
Accepted
2018-05-10 13:21:59
Documents
54
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20180331_10q.htm 10-Q 447897
2 EXHIBIT 31.1 ex_112872.htm EX-31.1 11173
3 EXHIBIT 31.2 ex_112873.htm EX-31.2 11168
4 EXHIBIT 32.1 ex_112874.htm EX-32.1 4565
5 EXHIBIT 32.2 ex_112875.htm EX-32.2 5656
  Complete submission text file 0001437749-18-009379.txt   2664726

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcda-20180331.xml EX-101.INS 473530
7 XBRL TAXONOMY EXTENSION SCHEMA bcda-20180331.xsd EX-101.SCH 36132
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20180331_cal.xml EX-101.CAL 26291
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20180331_def.xml EX-101.DEF 215907
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20180331_lab.xml EX-101.LAB 189825
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20180331_pre.xml EX-101.PRE 236285
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21419 | Film No.: 18821570
SIC: 2836 Biological Products, (No Diagnostic Substances)